Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Re - Juvenile
View:
Post by Hopeforthebest on May 12, 2024 2:03pm

Re - Juvenile

proph wrote and never did answer questions "With PGX expected to reach the decision point for mass industrialization in Q3 2024 with the commisioning  of the 100L scale-up the potential for Juvente has never been stronger"

Well proph, based on $30,000 per years of sales it can't really get any weaker can it? Secondly, gagnon cannot even complete promised the scale up of PGX on time, SIX MONTHS past due, and you are spewing about a 100l plant, thanks for the laugh.
By the way how much $$$$$ is gagnon pulling out of Juvente as CEO????? HOW MUCH or you afraid of answering the question without the garbage you just wrote. 
Comment by prophetoffactz on May 13, 2024 9:37am
Nov. 29, 2023 news release: "The 50L capacity to be completed by year-end and commissioned by end of Q1 2024..." April 29, 2024 news release: "Three trial runs of yeast beta glucan have been performed..." They've not only commissioned the 50L scale-up. CZO has now run three trial runs now.  "This project is almost completed." "Subject to approval ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities